admin, Autore presso Biotech Academy in Rome

Tips for Students: How to prepare careers in Biotech

Category

Tips for Students: How to prepare careers in Biotech

Preparing for a career in biotech requires a combination of academic preparation, practical skills development, networking, and staying abreast of industry trends.

Here are some tips for students interested in pursuing careers in biotech:

Get a Strong Educational Foundation: Focus on obtaining a solid education in relevant fields such as biology, chemistry, biochemistry, molecular biology, or biotechnology. Pursue advanced degrees if possible, such as a Master’s or Ph.D., depending on your career goals.

Gain Hands-on Experience: Seek out internships, co-op programs, or research opportunities in biotech companies, academic labs, or research institutions. Hands on experience is invaluable in the biotech industry and can help you develop practical skills and build a network of professionals.

Stay Updated on Industry Trends: Follow industry news, read scientific journals, and attend conferences or seminars to stay informed about the latest developments and trends in biotechnology. This will help you understand the current landscape and anticipate future opportunities and challenges.

Develop Technical Skills: Hone your laboratory skills, including techniques such as PCR, cell culture, protein purification, genetic engineering, and bioinformatics. Familiarize yourself with relevant software and instrumentation used in biotech research and development.

Build a Professional Network: Connect with professionals in the biotech industry through networking events, online forums, and professional organizations such as the Biotechnology Innovation Organization (BIO) or local biotech associations. Building relationships with mentors and peers can provide valuable insights and opportunities.

Enhance Soft Skills: In addition to technical expertise, cultivate soft skills such as communication, teamwork, problem-solving, and adaptability. These skills are essential for success in collaborative research environments and in interacting with colleagues, clients, and stakeholders.

Gain Business Acumen: Understand the business side of biotechnology, including regulatory requirements, intellectual property considerations, project management, and commercialization strategies. Courses or workshops in biotech entrepreneurship or business development can be beneficial.

Seek Mentorship and Guidance: Find mentors within the biotech industry who can offer advice, guidance, and support as you navigate your career path. Learn from their experiences and seek opportunities for mentorship and professional development.

Stay Flexible and Open-Minded: The biotech industry is dynamic and constantly evolving, so be prepared to adapt to changing circumstances and opportunities. Keep an open mind to exploring different career paths within biotech and be willing to take on new challenges and experiences.

Leonardo Sibilio
CEO of Biotech Academy in Rome

Social Share

What happened to synthetic DNA?

Category

What happened to synthetic DNA?

Not long ago, the synthetic DNA seemed to have a brilliant future as potential replacement of the plasmid DNA used for gene therapies.

The increasing number of gen therapy projects in-progress, boosted by the success of different treatments for its commercial distribution, depicted a promising landscape for smart technologies that, involving much lower volumes and apparently less operational complexity than plasmid production, clearly identified a business opportunity.

From 2019, a few initiatives were added to the existing ones, offering a product that was available for customer quite straight forward, avoiding the queue necessary to obtain good plasmid from a relevant supplier.

Not only, due to its simplicity, the synthetic DNA promised to be safer, free of undesired sequences and better characterized than plasmids. Some of these new companies has put the synthetic DNA in clinical trials.

However, five years later, all the energy exhibited by synthetic DNA companies seems to have evaporated, with some exception. What has happened? Why this lost of interest or this lost of target hitting by those developers/manufacturers of this new technology? It is true that the market environment has not been the most favorable for a sector which is very much dependant on finance rounds, the Russia-Ukranie war and the endless problems in international commerce did not help, but the product is still good. Analytical results are not an opinion and they clearly show that synthetic DNA is free -or almost- of bacterial sequences. The practice demonstrates that huge mounts of synthetic DNA can be obtained in a surprisingly short periods of time, where is then the problem? In my opinion there are a few points that may explain this decay of the synthetic DNA:

1. There are products in the market produced with plasmid, which means that plasmid is good enough for regulators. Against such a business card, you need to do an extraordinary effort to defend a new product and make it attractive enough to make therapy developers assume the risk involved in the novelty.

2. When the product is new, the manufacturer needs to assess the customers on the use of this product closely and patiently, invest time and resources and go side by side with the therapy developer to facilitate the risk mitigation.

3. There is a regulatory front that cannot be ignored, where the simplicity of the synthetic DNA should have a clear advantage versus the plasmid. Have the manufacturers of synthetic DNA profited of this potential?

Finally, there is a niche in my opinion waiting for the synthetic DNA, although is not clear how long it may last. I am talking about the association of synthetic DNA with non-viral vectors, another emerging technology. Both together could make a brilliant solution of the synthetic biology applied to gene therapies, but compromised investors, strong determination and clarity of ideas will be necessary. Do they exist?

Alfredo Martínez Mogarra
CSO of Biotech Academy in Rome

Social Share

The level of manufacturing quality and the matrioskas

Category

The level of manufacturing quality and the matrioskas

When we design a manufacturing process, we absolutely need to pay attention to the quality of our product. The quality is built from different sources and has to be present from the earliest pahses of our development process.

Let’s keep a quick view of some aspects seriously impacting the product quality:

Cell line: We need to use a very well identified and characterized cell line. This cell line has to be controlled as part of the process development to ensure that the product will be the same all the time.
Process components: It is necessary to know the origin and the procedures to obtain the different elements entering in our manufacturing process, making sure that we control its variability and specifications.
Utilities: Air and other gases, process water, steam… All utiiities must be compliant with certain regulations, all well indicated in different industry guidelines. The same situation applies to process equipment, consumables, classification of areas and all elements involved in the manufacturing of a biological molecule intended for therapeutic use.

Quality means a relevant part of the investment budget. Just the validation of a new manufacturing site takes usually 15% of the construction and equipment acquisition budget, meaning that if we build a 20 million facility to produce biosimilars, as an example, we need to add three more million to get it validated. Neither negligible are the sums that we are going to spend in the validation of the process and analytical methods. The validation of a manufacturing process will take no less than 2 to 4 million to which we have to add the money we will spend in the PPQ runs.

But what I wanted to underline today is how we manage the “hardware” around our process, the number and kind of suites for manufacturing, the quality of components and the level of demand that we are going to impose to our process.

The whole thing has a clear and well identified origin: patient’s safety. This is a red-line that we cannot trespass at all and this is the only real conditionant for the elements making part of our process and facility. In this sense, quality is like a set of russian dolls, so called “matrioskas”. These dolls are all equal to each other but for their size. There is a smallest one which enters in other slightly bigger, this in another one still bigger and so on, until reaching the biggest. Now let’s look to our quality set of measures as if they were russian dolls. The biggest one, the largest matrioska, is the quality that we apply to the manufacturing of a parenteral drug product. This product goes directly to patient’s body and, because of this, any little mistake can be fatal; therefore any precaution is welcome and any expense is assumable. As long as we move to the inside of the matrioska set, we reduce the level of demand of our quality procedures or, better said, we go to less demanding quality standards. Let’s consider this example to illustrate the situation: if we fill vials to inject into a patient, we need a class A surrounded by a class B environment to secure sterility; to make a cell passage during the production we just need a class A in a class C or D, because the biggest disaster that we can produce is the contamination of the next culture stage, which is usually an assumable risk. Did I say risk? Yes, I did. Risk assessment is the key instrument that will allow us to establish the level of demand that we need in the design of our facility.

In recent times I am observing a trend to overreact in terms of quality in facilities dedicated to new therapies. Declare a cell culture process “sterile” is not helping any patient, instead, it is incredibly complicating the operation and making the product more expensive and therefore, of more difficult access to patients. It is in the duties of quality officers and regulators to find the proper compromise between quality and cost, secure patients safety and not making the products harder to obtain by the patients population.

Alfredo Martínez Mogarra
CSO of Biotechnology Academy in Rome

Social Share

QRM Quality Risk Management & Process Development

Category

QRM Quality Risk Management & Process Development

We welcome Irwin Hirsh, Owner & Principal Consultant at Q-Specialists AB for his generous contribute to our blog section. Irwin specializes on improving business efficiency & effectiveness whilst ensuring business continuity through the implementation of digital tools for knowledge management.

In this short video Irwin introduces the importance of Quality Risk Management during Process Development.

At Biotech Academy in Rome we are glad to host Irwin Hirsh on our website and look forward to starting a fruitful collaboration.

Social Share

Navigating in the Data-driven world of today: unlocking the power of tools for data analysis.

Category

Navigating in the Data-driven world of today: unlocking the power of tools for data analysis.

Andrea Conidi, PhD, Expert in functional “omics” Data Analysis.

In our contemporary landscape, the world is undergoing a radical transformation fueled by the exponential growth and availability of data. In every sector, from finance to healthcare, from manufacturing to biopharma, the ability to extract valuable insights from vast datasets has become a critical determinant of success. The shift towards a data-driven paradigm underscores the indispensable role of data science in planning business and research strategies.

Data science is the approach to unravel patterns, trends and correlations within massive datasets that might be otherwise overlooked. In a world inundated with information the ability to extract meaningful insights allows organizations to make informed decisions, optimize processes and identify new opportunities for growth, while at the same time reducing risks. Companies that embrace data science find themselves at the forefront of progress, constantly pushing boundaries and redefining what is possible.

The biopharmaceutical market is a clear example of a sector where data is central. The availability of big “Omics” datasets (Next Generation sequencing, proteomics, metabolomics, functional genomics) has pushed for the development of analysis tools to accelerate research, development and innovation. As the industry evolves, the extensive use of programming languages, such as R and Python, to extract data insights and develop new strategies has become crucial in such competitive market.

R is a statistical programming environment explicitly designed for data analysis and visualization. Developed by statisticians, R excels in statistical computing, making it a preferred choice for researchers in fields such as bioscience, biostatistics, epidemiology and social sciences. Its ease of use and its intuitive syntax make R as an ideal tool to start analyzing, visualizing and present research data without too much effort. Nowadays many packages are available to perform routine analysis of, for example, RNA-sequencing (both at bulk and single-cell level) or genomic-data.

Python, while excelling in data science, is a general-purpose language that extend beyond statistical analysis. Its versatility makes it suitable for a broader range of applications from web-development to automation and artificial intelligence.

Both R and Python have robust helpful and friendly communities, with R being more focused and aimed to researchers and statisticians including those with no or basic programming knowledge. Python’s community is, on the other hand, composed of a larger and more diverse base. Choosing between the two languages might be confusing, especially for those who approach this world for the first time and it really depends on the needs.

In general, harnessing one or both programming languages is nowadays a requirement in the biopharmaceutical market for many aspects:

Informed Data-Driven Decisions: From clinical trial to genomic data, R and Python empower researches to gather meaningful insights, allowing informed decision-making at every stage of targets identifications or drug development process.

Streamlining Research and Development: The complexity of biopharma R&D demands efficient and scalable solutions. Python, with its versatility, and R, with its statistical prowess, offer a powerful combination. Researchers can develop and implement algorithms, models and simulations accelerating the discovery of novel drugs, optimizing experimental design and shortening development timelines.

Enhanced Collaboration and Reproducibility: The collaborative nature of biopharmaceutical research emphasizes the need for transparent and reproducible workflows. R and Python provide robust frameworks for creating shareable scripts and pipelines, not only advancing collaborations but also ensuring that analyses can be replicated and validated, promoting the reliability of the findings.

Customization and Scalability: Biopharma projects often demand tailor-made solutions to address unique challenges. Both R and Python excel in providing scalable and customizable solutions with scripts and visualization tools allowing for flexibility and adaptability to specific project requirements.

Integration with Advanced Technologies: The integration of R and Python with emerging technologies such as artificial intelligence and machine learning has revolutionized the biopharmaceutical landscape. These languages enable the development of predictive models, pattern recognition and advanced algorithms offering unprecedented insights into protein modelling, disease mechanisms and drug development.

As the demand for data-driven insights and technological advancements in biopharma grows, so does the need for professionals with expertise in R and Python. Research organizations (academic and private sectors) actively seeks individuals proficient in these two programming languages to handle big complex datasets and extract as much information as possible.

In conclusion, as our world becomes more and more interconnected and data-oriented, the role of data science becomes increasingly necessary: from shaping business strategies to driving innovation and decision-making. In this data-driven world, the ability to harness the power of data with programming languages as R and Python, is no longer just an advantage but a strategic requisite for those seeking to thrive in their respective fields.

We suggest: Introduction to R – Biotech Academy in Rome

Social Share

Why is technology transfer important in the biotech industry

Category

Why is technology transfer important in the biotech industry

Technology transfer plays a crucial role in the biotech industry for several reasons:

1. Innovation and Advancement: Technology transfer facilitates the dissemination of new discoveries, innovations, and advancements in biotechnology. This ensures that breakthroughs made in research labs can be translated into real-world applications, such as new drugs, therapies, diagnostic tools, and agricultural products.

2. Commercialization: Many groundbreaking discoveries in biotech originate from academic or government research institutions. Technology transfer enables these discoveries to be commercialized by transferring them to private companies capable of further developing, scaling, and bringing them to market.

3. Economic Growth: Biotechnology is a key driver of economic growth, creating jobs, generating revenue, and fostering innovation. Technology transfer helps to unlock the economic potential of biotech by facilitating the development of new products and services that address unmet needs in healthcare, agriculture, industry, and the environment.

4. Collaboration and Partnerships: Technology transfer often involves collaborations and partnerships between academia, government agencies, and private companies. These partnerships leverage the expertise, resources, and infrastructure of different stakeholders to accelerate the development and commercialization of biotech innovations.

5. Access to Expertise and Resources: Biotech companies may not always have the expertise or resources to develop every aspect of a new technology or product in-house. Technology transfer allows them to access external expertise, infrastructure, funding, and intellectual property rights to complement their own capabilities and accelerate development timelines.

6. Regulatory Compliance: Developing and commercializing biotech products often requires navigating complex regulatory pathways. Technology transfer can help ensure that companies have access to the necessary regulatory expertise and guidance to navigate these pathways efficiently and effectively.

Overall, technology transfer is essential for bridging the gap between scientific discovery and real-world impact in the biotech industry, driving innovation, economic growth, and improved societal outcomes.

Leonardo Sibilio

CEO Biotech Academy in Rome

Social Share

Exploring the role of Biotechnology in medicine

Category

Exploring the role of Biotechnology in medicine

Biotechnology has revolutionized medicine, offering groundbreaking solutions to previously incurable diseases and enabling more personalized approaches to healthcare. Here’s a deep dive into its role across various fronts:

1. Gene Therapy: Gene therapy involves modifying or replacing defective genes to treat or prevent diseases. It holds immense promise for treating genetic disorders like cystic fibrosis, hemophilia, and certain types of cancer. By delivering functional genes into patients’ cells, gene therapy aims to correct the underlying genetic causes of diseases. Recent advancements in gene editing technologies like CRISPR have accelerated the development of precise and efficient gene therapies.

2. Personalized Medicine: Biotechnology has paved the way for personalized medicine, tailoring treatments to individual patients based on their genetic makeup, lifestyle, and environmental factors. Advances in genomics, proteomics, and bioinformatics have enabled the identification of biomarkers that predict a patient’s response to specific treatments. This approach allows for more targeted therapies, minimizing adverse effects and optimizing treatment outcomes. Pharmacogenomics, for instance, studies how genetic variations influence drug response, guiding the selection of medications that are most effective and safe for individual patients.

3. Vaccine Development: Biotechnology has transformed vaccine development, making the process faster, more efficient, and more precise. Techniques like recombinant DNA technology allow scientists to produce vaccines by inserting genes encoding viral antigens into host cells, which then produce the desired antigens for vaccination. This approach has been instrumental in the development of vaccines against diseases like hepatitis B, human papillomavirus (HPV), and COVID-19. Additionally, platforms such as mRNA vaccines, exemplified by the Pfizer-BioNTech and Moderna COVID-19 vaccines, represent a cutting-edge application of biotechnology that offers advantages in speed and flexibility over traditional vaccine approaches.

4. Biopharmaceuticals: Biotechnology plays a crucial role in the development of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and nucleic acid-based therapies. These therapeutic agents are engineered to target specific molecules involved in disease pathways, offering novel treatment options for conditions ranging from autoimmune disorders to cancer. Monoclonal antibodies, for example, can be designed to bind to and neutralize disease-causing molecules, providing targeted therapy with reduced side effects compared to conventional treatments.

5. Regenerative Medicine: Biotechnology has opened up avenues for regenerative medicine, aiming to repair or replace damaged tissues and organs using cells, biomaterials, and growth factors. Stem cell therapies, tissue engineering, and gene editing technologies hold promise for treating conditions like spinal cord injury, heart disease, and diabetes by restoring normal tissue function. While still in the early stages of development, regenerative medicine offers hope for addressing unmet medical needs and improving patients’ quality of life.

Overall, biotechnology continues to drive innovation in medicine, offering transformative solutions that hold the potential to revolutionize healthcare delivery and improve patient outcomes. As technology advances and our understanding of biology deepens, the impact of biotechnology in medicine is poised to grow exponentially, shaping the future of healthcare in profound ways.

Team Biotech Academy in Rome

Social Share

Empowering Tomorrow’s Medical Innovators

Category

Empowering Tomorrow’s Medical Innovators

Biotech education plays a critical role in preparing the next generation of scientists and innovators in the field of medicine for several reasons:

1. Understanding Cutting-Edge Technologies: Biotech education exposes students to the latest advancements in technology, such as gene editing, personalized medicine, and regenerative therapies. This knowledge equips them to tackle complex medical challenges and develop innovative solutions.

2. Interdisciplinary Approach: Biotech education typically integrates principles from biology, chemistry, physics, engineering, and computer science. This interdisciplinary approach fosters creativity and encourages students to think outside traditional disciplinary boundaries, essential for addressing multifaceted medical issues.

3. Hands-on Experience: Many biotech education programs emphasize hands-on laboratory experience, allowing students to develop essential research skills and techniques early in their academic careers. This practical training prepares them for careers in research and development within the medical field.

4. Ethical Considerations: Biotech education also emphasizes the ethical implications of scientific research and technological advancements in medicine. Students learn to navigate complex ethical dilemmas, ensuring that future innovations in biotech are both scientifically sound and ethically responsible.

5. Collaboration and Teamwork: Medicine is increasingly becoming a team-based endeavor, requiring collaboration between scientists, clinicians, engineers, and other professionals. Biotech education fosters collaboration skills by encouraging students to work in interdisciplinary teams on projects and research initiatives.

6. Innovation and Entrepreneurship: Biotech education encourages an entrepreneurial mindset, empowering students to translate scientific discoveries into real-world applications. This fosters innovation and cultivates a new generation of biotech entrepreneurs who can bring novel medical treatments and technologies to market.

7. Addressing Global Health Challenges: Biotech education equips students with the knowledge and skills needed to address global health challenges, such as infectious diseases, cancer, and chronic illnesses. By training the next generation of scientists and innovators, biotech education contributes to improving healthcare outcomes worldwide.

In conclusion, biotech education is essential for preparing the next generation of scientists and innovators in the field of medicine by providing them with the knowledge, skills, and ethical framework necessary to tackle complex medical challenges, drive innovation, and improve global health outcomes.

As we open the doors to the magic happening within our Biotech Academy in Rome, we invite you to join us on this journey of discovery and growth. Behind every successful experiment and breakthrough is a passionate learner, and at Biotech Academy in Rome, we’re shaping the future pioneers of the biotech industry.

Dr. Valerio Branchi

President – Biotech Academy in Rome

Social Share

Brief history of biotechnology and its evolution over the years

Category

Brief history of biotechnology and its evolution over the years

Biotechnology, a field at the intersection of biology and technology, has a rich history marked by significant milestones and breakthroughs that have transformed medicine, agriculture, industry, and beyond. Here’s a brief overview:

1. Ancient Biotechnology (Pre-1600s): Biotechnological practices, though not recognized as such, have roots in ancient civilizations. Practices like fermentation for food preservation, brewing, and cheese making were early examples of biotechnological processes.

2. Discovery of Cells (17th Century): The discovery of cells by Robert Hooke in 1665 laid the foundation for understanding the basic unit of life, setting the stage for future advancements in biotechnology.

3. Fermentation Studies (Late 19th Century): Louis Pasteur’s work on fermentation in the late 19th century elucidated the role of microorganisms in the process, establishing the basis for industrial microbiology and bioprocessing.

4. Genetics Emergence (Early 20th Century): The rediscovery of Gregor Mendel’s work on genetics in the early 20th century and subsequent advancements in understanding the principles of heredity laid the groundwork for modern genetic engineering.

5. Discovery of DNA (1950s): The discovery of the structure of DNA by James Watson and Francis Crick in 1953 revolutionized biology and paved the way for modern biotechnology, enabling scientists to understand the molecular basis of life and genetic inheritance.

6. Recombinant DNA Technology (1970s): The development of recombinant DNA technology in the 1970s allowed scientists to manipulate and modify genetic material, leading to the birth of genetic engineering and the production of genetically modified organisms (GMOs).

7. Biopharmaceuticals (1980s): The 1980s saw the emergence of biopharmaceuticals, with the production of insulin using recombinant DNA technology marking a significant milestone in the field of medicine.

8. Genome Sequencing (1990s): The completion of the Human Genome Project in the 1990s, along with advancements in DNA sequencing technology, opened new avenues for understanding genetics and paved the way for personalized medicine and gene therapy.

9. CRISPR-Cas9 (2010s): The development of the CRISPR-Cas9 gene editing technology in the early 2010s revolutionized genetic engineering, offering a precise, efficient, and versatile tool for editing genomes with wide-ranging applications in research, medicine, and agriculture.

10. Synthetic Biology (21st Century): The 21st century has seen the rise of synthetic biology, a multidisciplinary field that combines principles of engineering and biology to design and construct new biological systems and organisms for various applications, including biofuel production, bioremediation, and drug development.

These milestones represent just a fraction of the advancements and discoveries that have shaped the field of biotechnology. As technology continues to evolve, biotechnology is poised to play an increasingly prominent role in addressing global challenges and improving the quality of life for people around the world.

Team Biotech Academy in Rome

Social Share

Behind the Scenes at Biotech Academy in Rome: Unveiling the Magic of Hands-On Training!

Category

Behind the Scenes at Biotech Academy in Rome: Unveiling the Magic of Hands-On Training!

🔬✨ Behind the Scenes at Biotech Academy in Rome: Unveiling the Magic of Hands-On Training!
Ever wondered what goes on behind the closed doors of our Biotech Academy in the heart of Rome? Today, we’re pulling back the curtain to give you an exclusive sneak peek into the captivating world of our cutting-edge biotechnology training programs.

👩‍🔬 Small Personalized Groups for Maximum Impact 👨‍🔬
At Biotech Academy in Rome, we believe in quality over quantity. That’s why we keep our training groups small and intimate, ensuring that each student receives personalized attention from our expert instructors. This approach allows us to tailor the learning experience to individual needs, fostering a dynamic environment where questions are encouraged, and discussions thrive.

🤲 Hands-On Training: Learning by Doing 🧤
Our training philosophy revolves around the power of hands-on experience. Our state-of-the-art labs are buzzing with energy as students dive into real-world experiments and projects. From genetic engineering to advanced bioprocessing techniques, our participants get their hands dirty (sometimes quite literally) while mastering the practical skills that define the biotech industry.

🌐 Connecting Theory with Practice 🧪
In our Biotech Academy in Rome, the divide between theory and practice is virtually nonexistent. Students not only grasp the theoretical foundations but also see how they come to life in the lab. This holistic approach ensures that our graduates are not just well-versed in biotechnology concepts but are ready to apply their knowledge in real-world scenarios.

👥 Building a Community of Future Innovators🌟
Beyond the technical aspects, the Biotech Academy in Rome is a hub for fostering connections and collaborations. Our students form a tight-knit community of like-minded individuals, sharing ideas and sparking innovation. Networking events and collaborative projects are integral parts of our training, preparing students for the teamwork often required in the dynamic field of biotechnology.

🚀 Launching Careers, One Experiment at a Time 🎓
As we open the doors to the magic happening within our Biotech Academy in Rome, we invite you to join us on this journey of discovery and growth. Behind every successful experiment and breakthrough is a passionate learner, and at Biotech Academy in Rome, we’re shaping the future pioneers of the biotech industry.

Stay tuned for more behind-the-scenes glimpses into the world of biotechnology education. The future is bright, and it’s being crafted by the hands of our Biotech Academy graduates! 🔍🔬💡 #BiotechAcademy #BehindTheScenes #HandsOnTraining #Biotech #gmp #pharma #lifescience